RS50975B - Compositions comprising drospirenone molecularly dispersed - Google Patents

Compositions comprising drospirenone molecularly dispersed

Info

Publication number
RS50975B
RS50975B RSP-2009/0307A RSP20090307A RS50975B RS 50975 B RS50975 B RS 50975B RS P20090307 A RSP20090307 A RS P20090307A RS 50975 B RS50975 B RS 50975B
Authority
RS
Serbia
Prior art keywords
compositions
molecularly dispersed
drospirenone
drospirenone molecularly
solid
Prior art date
Application number
RSP-2009/0307A
Other languages
Serbian (sr)
Inventor
Adrian Funke
Torsten Wagner
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Priority claimed from PCT/IB2005/000665 external-priority patent/WO2005087194A1/en
Publication of RS50975B publication Critical patent/RS50975B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tvrda ili polu-tvrda kompozicija adaptirana za oralnu administraciju, naznačena time, da obuhvata Drospirenon koji je molekularno dispergovan i najmanje jednog farmaceutski prihvatljivog kerijera.Prijava sadrži još 12 patentnih zahteva.A solid or semi-solid composition adapted for oral administration comprising Drospirenone which is molecularly dispersed and at least one pharmaceutically acceptable carrier. The application further comprises 12 claims.

RSP-2009/0307A 2004-03-10 2005-03-10 Compositions comprising drospirenone molecularly dispersed RS50975B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55135504P 2004-03-10 2004-03-10
EP04075713 2004-03-10
PCT/IB2005/000665 WO2005087194A1 (en) 2004-03-10 2005-03-10 Compositions comprising drospirenone molecularly dispersed

Publications (1)

Publication Number Publication Date
RS50975B true RS50975B (en) 2010-10-31

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0307A RS50975B (en) 2004-03-10 2005-03-10 Compositions comprising drospirenone molecularly dispersed

Country Status (12)

Country Link
CN (1) CN1980636A (en)
AR (1) AR048002A1 (en)
DE (1) DE602005022952D1 (en)
GT (1) GT200500044A (en)
MY (1) MY143870A (en)
PA (1) PA8625901A1 (en)
PE (1) PE20060004A1 (en)
RS (1) RS50975B (en)
SV (1) SV2005002043A (en)
TW (2) TW200840587A (en)
UA (1) UA90263C2 (en)
UY (1) UY28802A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (en) * 2016-08-11 2018-07-06 吴启旸 Eplerenone solid dispersions and its preparation

Also Published As

Publication number Publication date
TW200840587A (en) 2008-10-16
SV2005002043A (en) 2005-11-04
MY143870A (en) 2011-07-15
TW200609000A (en) 2006-03-16
UA90263C2 (en) 2010-04-26
GT200500044A (en) 2005-10-31
UY28802A1 (en) 2005-10-31
PA8625901A1 (en) 2006-07-03
CN1980636A (en) 2007-06-13
DE602005022952D1 (en) 2010-09-23
PE20060004A1 (en) 2006-02-16
AR048002A1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
LTPA2018502I1 (en) Oral Cladribine Compositions
CY1116023T1 (en) FORMS OF PHARMACEUTICAL DOSAGE CONTROLLED DETERMINATION WITH PHARMACEUTICAL DISSOLUTION LIMITATIONS
BG66093B1 (en) Controlled release compositions comprising nimesulide
MEP39108A (en) Pharmaceutical composition
RS54275B1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
NO20073026L (en) 2-Alkoxy-3,4,5-trihydroxyalkylamides, preparation and compositions thereof, and use thereof
RS50768B (en) Dosage regimen and pharmaceutical composition for emergency contraception
DE602006020605D1 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
BRPI0500536A (en) Antimicrobial Composition
ATE268175T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DECURSIN
RS51534B (en) NEW ASSOCIATION OF AN If SINUSOIDAL CURRENT INHIBITOR AND A CALCIUM CHANNEL-BLOCKING AGENT, AND PHARMACEUTICAL INGREDIENTS CONTAINING SAID ASSOCIATION
FR12C0064I2 (en) INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHRACENEDIONE DERIVATIVE WITH ANTITUMOR ACTION
DE60301261D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINED 17ALPHA-FURANYLESTER OF 17BETA-CARBOTHIOAT ANDROSTANE DERIVATIVES AND A MUSCARIN RECEPTOR ANTAGONIST
RS50975B (en) Compositions comprising drospirenone molecularly dispersed
ATE412404T1 (en) STABLE ORAL PHARMACEUTICAL COMPOSITIONS OF BUPRENORPHINE AND SALT THEREOF
BR0206960A (en) Oral pharmaceutical composition and use of a hydroxypropyl methylcellulose phthalate polymer
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
HRP20090547T1 (en) Pharmaceutical compositions comprising zd6474
UY27628A1 (en) "2'-HALO -3 ', 5'-DIALCOXI-FEN-1'IL-2-IMIDAZOLIDINS AND ITS USE AS A DRUG"
BR0001144B1 (en) PHARMACEUTICAL COMPOSITION OF VITAMIN-E, PAPAINE AND HYALURONIDASE-BASED DICLOPHENAC
WO2005037247A3 (en) Oral matrix formulations of doxazosin
AR040135A1 (en) NEW FORMULATION FOR PARENTERAL ADMINISTRATION OF CROBENETINE (BIII 890)